Chemokines are a group of small, structurally related, and frequently heparin-binding cytokines that provide important signals for leukocyte migration through induction of cell motility and activation of adhesion molecules (Baggiolini et al., 1994; Schall and Bacon, 1994 kine appears to act preferentially on lymphocytes (Baggiolini et al., 1994; Schall and Bacon, 1994; Rollins, 1997) . Chemokine receptors identified to date on leukoSummary cytes all manifest a seven transmembrane (7-TM) G protein-linked architecture (Murphy, 1994; Premack and Leukocyte trafficking at the endothelium requires both Schall, 1996) . It is known that they transduce signals cellular adhesion molecules and chemotactic factors.
Introduction tic activity for monocytes and T cells. Thus, fractalkine is a versatile molecule regulating both cell-cell interacBlood leukocytes rapidly emigrate into sites of injury or tions as the membrane-bound form and directed cell infection, while mature lymphocytes continually recircumigration by its soluble form. late between blood and tissues. These migratory proper-
The novel structure and functions of fractalkine sugties of blood leukocytes and circulating lymphocytes gest that it may play a key role in the multistep process are essential for host defense and immunological surof leukocyte trafficking, while raising several issues. It veillance. The molecular control of these essential trafis not known whether fractalkine induces both its migraficking events requires two broad classes of molecules: tory and adhesive effects directly and whether it funcvarious cell adhesion molecules, especially those of setions through a standard 7-TM chemokine receptor, an lectins and integrins, as well as leukocyte chemotactic adhesion counter receptor, or a combination of both. factors including the members of the chemokine superWe set out to address these questions first by identifying family (Butcher, 1991; Springer, 1994; Butcher and Picker, the fractalkine receptor and then to use this information 1996). Chemokines have been postulated to work in conto dissect the molecular functions of the receptor-ligand cert with adhesion molecules in selective trafficking of pair. We report here the identification of a high-affinity specific leukocyte classes and lymphocyte subsets, yet functional receptor for fractalkine, CX 3 CR1, and how many of the molecular workings of these processes refractalkine and CX 3CR1 directly mediate the adhesion main to be elucidated.
and migration of leukocytes such as monocytes and NK cells. Our findings suggest that fractalkine and CX 3 CR1 represent a new class of leukocyte trafficking regulator, § Present Address: Molecular Medicine Research Institute, 325 E.
where the hybrid functions of both adhesion and migraMiddlefield Road, Mt. View, California 94043.
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tion are combined at molecular and functional levels. Previous studies have shown that chemokines fused with the secreted form of placental alkaline phosphatase (SEAP) retain their ability to bind specifically to their cellsurface receptors, while the phosphatase activity allows that lymphocytes and monocytes express a single class of high-affinity receptors for fractalkine. quantitative determination of specific binding (Luster et al., 1995; Imai et al., 1997) . To prepare labeled fractalkine for receptor binding experiments, we expressed soluble V28 Is a High-Affinity Functional Receptor for Fractalkine fractalkine fused with SEAP (Fractalkine-SEAP). As shown in Figure 1A , purified Fractalkine-SEAP exhibited To identify the fractalkine receptor, we tested the binding of Fractalkine-SEAP to the seven known CC chemoa broad band with an apparent molecular mass of 150 kDa, consistent with the observed M r of the soluble form kine receptors (CCR1-CCR7) Rollins, 1997; Yoshida et al., 1997) and several (Bazan et al., 1997) with the added mass of SEAP and (His)6. To characterize fractalkine receptor, we first car-"orphan" receptors: BLR1 (Dobner et al., 1992) , V28 (Combadiere et al., 1995; Raport et al., 1995) , and GPRried out Fractalkine-SEAP binding experiments using peripheral blood lymphocytes and monocytes known to 9-6 (GenBank accession number: HSU45982). Of the receptors tested, Fractalkine-SEAP bound specifically respond to fractalkine (Bazan et al., 1997) . When the binding was performed with increasing concentrations to V28 expressed on K562 ( Figure 2A ) as well as on Raji and 293/EBNA-1 (data not shown). When the binding of Fractalkine-SEAP, a single class of receptors was revealed on lymphocytes with a K d of 30 pM and 440 was performed with increasing concentrations of Fractalkine-SEAP, K562-V28 demonstrated a single class of sites per cell ( Figure 1B ) and on monocytes with a K d of 50 pM and 450 sites per cell ( Figure 1C ). These results receptors for Fractalkine-SEAP with a K d of 100 pM and 20,000 sites per cell ( Figure 2B ). This high-affinity bindclearly demonstrated that Fractalkine-SEAP functions as a high-affinity ligand for the fractalkine receptor, and ing of Fractalkine-SEAP to V28 was quite consistent with those obtained with the endogenous fractalkine in Figure 3A , K562, 293/EBNA-1, and Raji transfected with V28 efficiently adhered to immobilized Fractalkinereceptors expressed on lymphocytes and monocytes ( Figure 1) .
SEAP, but not to SEAP alone. The cells transfected with the vector alone did not adhere to immobilized FractalWe next tested whether V28 was a functional receptor for fractalkine. As shown in Figure 2C , soluble fractalkine kine-SEAP or SEAP at all. Adhesion of V28-transfected cells to immobilized Fractalkine-SEAP appeared to be induced a vigorous migration of V28-transfected 293/ EBNA-1 cells with a typical bell-shaped dose-response quite rapid, since most cells were already bound during a few min at room temperature while they were allowed curve and a maximum effect at 1 nM. 293/EBNA-1 cells transfected with the vector alone did not respond to to settle down at 1ϫ g. The adhesion was also quite stable even when cells were incubated at 37ЊC for 1 hr. fractalkine at all. A checkerboard-type analysis indicated that the migration of V28-transfected 293/EBNA-1 This contrasted to the previous observation that adhesion of T cells and monocytes to fractalkine-expressing cells toward soluble fractalkine was mostly chemotactic (data not shown). As shown in Figure 2D , fractalkine also HEK 293 cells was transient (Bazan et al., 1997) . This may suggest adhesion-regulatory activity by these types induced a vigorous calcium flux in K562 cells expressing V28 with complete desensitization to successive stimuof cells, such as cleavage of cell surface fractalkine sometime after cell-cell binding. Another notable point lation with fractalkine. No such response to fractalkine was seen in parental K562 cells or those transfected with was that, in contrast to V28-transfected K562 and 293/ EBNA-1 cells, V28-transfected Raji cells did not respond the vector alone (data not shown). Fractalkine-induced calcium mobilization in K562-V28 cells was detectable to soluble fractalkine in the calcium mobilization assay at all ( Figure 3B ). We confirmed that the levels of V28 at 0.1 nM and reached a maximum level at 10 nM with an EC 50 of 2 nM (data not shown). Furthermore, pretreatexpression on the cell surface of K562, 293/EBNA-1, and Raji as determined by the Fractalkine-SEAP binding ment of K562-V28 cells with PT completely abolished this calcium mobilization ( Figure 2D ), indicating signal assay (see below) were quite similar (data not shown). This implied that calcium mobilization might not be retransduction through G␣i-class G proteins. These observations clearly demonstrated that V28 was indeed a quired for V28-mediated adhesion by fractalkine. We further investigated the role of signaling via V28 functional receptor for fractalkine.
in fractalkine-induced adhesion. As shown in Figure 3C , soluble fractalkine (SFK) was found to suppress com-V28 Mediates Cell Adhesion We next examined whether fractalkine supports adhepletely the adhesion of K562-V28 to immobilized Fractalkine-SEAP. This was striking because soluble fractalsion of V28-expressing cells. To minimize involvement of other cell adhesion molecules acting in parallel or in kine itself was a potent agonist for V28 in chemotaxis and calcium mobilization ( Figure 2 ). The adhesion was trans, we used glass slides on which Fractalkine-SEAP was immobilized through anti-SEAP antibody. As shown also almost completely suppressed at 4ЊC. On the other hand, adhesion of K562-V28 to Fractalkine-SEAP was not affected at all by depletion of divalent cations with EDTA/EGTA. The same treatment was separately confirmed to suppress completely the integrin-mediated cell aggregation of peripheral blood mononuclear cells induced by phorbol myristate acetate (data not shown). Furthermore, PT did not strongly affect the ability of K562-V28 to adhere to immobilized Fractalkine-SEAP, even though the same treatment completely suppressed calcium mobilization in K562-V28 by soluble fractalkine ( Figure 2B ). We also confirmed that cholera toxin, which is known to inhibit the Gs class of G proteins, did not affect the adhesion either (data not shown). The effect of PT was further examined by using 293/EBNA-1 cells.
As shown in Figure 3D , PT had no inhibitory effect on adhesion of V28-expressing 293/EBNA-1 to immobilized Fractalkine-SEAP while it completely inhibited calcium flux and chemotaxis in the same cells induced by soluble fractalkine. Collectively, immobilized Fractalkine-SEAP appeared to induce stable adhesion of V28-expressing cells without involving additional adhesion molecules such as integrins or selectins and without signaling through PT-sensitive G proteins. The temperature dependence of adhesion might indicate involvement of other signaling pathways or necessity of membrane fluidity to allow multiple associations.
Roles of the Chemokine and Mucin Domains in Adhesion
To define the respective roles of the chemokine and mucin domains of fractalkine in adhesion, we next generated three representative mutants: (1) Mucin-SEAP lacking the CX3C-chemokine domain; (2) CX3C-SEAP lacking the mucin domain; and (3) TARC-Mucin-SEAP, a chimera where the CX3C domain was replaced by a CC chemokine TARC . We first determined the domain responsible for V28 binding. As shown main failed to support the adhesion of K562-V28 cells, even though soluble CX 3 C-SEAP bound to V28 as effiMucin-SEAP. Furthermore, TARC, but not soluble fracciently as soluble Fractalkine-SEAP ( Figure 4A ). Thus, talkine, inhibited K562-CCR4 adhesion to immobilized the mucin domain appeared to be somehow involved TARC-Mucin-SEAP. Another important point was that in the adhesion process. The combination of the two K562-CCR4 cells again failed to adhere efficiently to mutants (CX 3 C-SEAP ϩ Mucin-SEAP), however, failed immobilized TARC-SEAP lacking the mucin domain. to support the adhesion in trans. Unexpectedly, when
To further test the respective roles of the chemokine we carried out the same experiments using CCR4-and mucin domains in adhesion, we assessed inhibitory expressing K562 cells ( Figure 4C ), these cells were activity of various soluble SEAP fusion proteins on adhefound to adhere efficiently to immobilized TARC-Mucinsion of K562-V28 cells to immobilized Fractalkine-SEAP. SEAP. This adhesion was mediated by the specific inter-
In these experiments, Fractalkine-SEAP was directly imaction of CCR4 and TARC , since K562-CCR4 did not adhere to SEAP, Fractalkine-SEAP, or mobilized onto glass slides. As shown in Figure 4D , not be directly involved in adhesion; the data strongly suggest that the chemokine domain and V28 were solely responsible for direct receptor engagement and adhesion.
Expression of V28 and Fractalkine Receptor in Leukocyte Classes and Subsets
We next proceeded to determine the expression of V28 mRNA and surface fractalkine receptor in various types of leukocytes. As shown in Figure 5A , among freshly isolated normal peripheral blood leukocytes, V28 mRNA was expressed mainly in CD16 ϩ natural killer (NK) cells. After long exposure, low levels of the mRNA were detected in CD3 ϩ T cells, CD14 ϩ monocytes (Mo), and granulocytes (Gr), while CD19 ϩ B cells were virtually negative. Expression of V28 mRNA in both CD4 ϩ and CD8 ϩ T cells was strongly up-regulated by IL-2 ( Figure  5A ). The effect of IL-2 was, however, completely suppressed by cotreatment with phytohemagglutinin (PHA). Thus, the expression of V28 in T cells is positively regulated by IL-2 but negatively regulated by T-cell activation like those of CCR1 and CCR2 (Loetscher et al., 1996) . To assess surface expression of fractalkine receptor on various leukocyte subsets, cells were incubated with Fractalkine-SEAP and then reacted with biotinylated anti-SEAP antibody. Subsequently, cells were doublestained with FITC-labeled streptavidin and with PElabeled antibody for indicated surface makers ( Figure  5B ). As summarized in Figure 5C , most CD16 ϩ NK cells ‫)%29ف(‬ were positive for fractalkine receptor. A subpopulation of CD3 ϩ T cells ‫)%41ف(‬ also expressed fractalkine receptor. The CD3 ϩ T cells that expressed fractalkine receptor were mostly CD8 ϩ T cells, although some individuals contained both CD4 ϩ and CD8 ϩ T cells expressing fractalkine receptor at similar levels as shown in Figure 5B . Very few CD19 ϩ B cells expressed fractalkine receptor. The surface expression pattern of the fractalkine receptor on lymphocytes thus correlates well with toward fractalkine by using the transendothelial migrawashing, cells were analyzed on a FACStar Plus gating for lymphotion assay (Carr et al., 1994; Oin et al., 1996) . Soluble response at 10 nM ( Figure 6A ). The efficacy of fractalkine was comparable to that of MCP-1 in lymphocyte chemotaxis (see below). The efficacy of fractalkine was, hownot only soluble Fractalkine-SEAP but also CX 3 C-SEAP without the mucin domain strongly suppressed the adever, much lower than MCP-1 in monocyte chemotaxis (1.5% versus 30.7%). Among the lymphocyte subpopuhesion of K562-V28 to immobilized Fractalkine-SEAP. On the other hand, Mucin-SEAP or TARC-Mucin-SEAP, lations, soluble fractalkine induced efficient migration in CD16 ϩ NK cells and, to a lesser extent, in CD3 ϩ CD8 ϩ both having the mucin domain, had virtually no inhibitory effect on the adhesion. Thus, the mucin domain might T cells ( Figure 6B ). CD3 ϩ CD4 ϩ T cells also migrated to V28 (A and B) or normal NK cells (C) were applied to wells and (B) Subsets of lymphocytes migrating to soluble fractalkine. Cells incubated for 20 min at room temperature. After washing off nonadmigrated to soluble fractalkine were collected, stained with FITCherent cells by dipping the slides gently in assay buffer twice, adherconjugated or PE-conjugated antibodies for indicated surface makent cells were fixed with 1% glutaraldehyde. For treatment with ers, and subjected to flow cytometric analysis. Representative resoluble fractalkine or EGTA/EDTA (EG/ED), 10 g/ml of soluble fracsults from three different donors are shown.
talkine or 5 mM of EGTA/EDTA was added during the assay. For (C) Subsets of lymphocytes migrating to soluble fractalkine, TARC, treatment with PT, cells were pretreated with PT at 500 ng/ml for 1 and MCP-1. Cells that migrated to medium (open columns), 10 nM hr at 37ЊC. Adhered cells were counted in five 400ϫ fields (0.07 of soluble fractalkine (closed columns), 10 nM of TARC (shaded mm 2 ) per well. The data shown represent mean Ϯ SEM. Representacolumns), and 10 nM of MCP-1 (hatched columns) were collected, tive results from at least two independent experiments are shown. stained with FITC-conjugated or PE-conjugated antibodies for indicated surface makers, and subjected to flow cytometric analysis. Representative results from three different donors are shown. the subsets of leukocytes expressing V28 mRNA and fractalkine receptor on the surface. soluble fractalkine in some individuals at a very low efficiency (Ͻ0.6%). Both CD45RO ϩ memory and CD45RO
Ϫ naive cells migrated toward soluble fractalkine (data not Adhesion of V28-Expressing Cells to Membrane-Bound Fractalkine shown). No CD19
ϩ B cells migrated to soluble fractalkine at all. We further compared soluble fractalkine with TARC on Endothelium
We assessed the role of membrane-bound fractalkine and MCP-1 in the transendothelial migration assay (Figure 6C) . CD3 ϩ CD8 ϩ T cells were preferentially attracted in the adhesion of V28-expressing cells to endothelial cells. As shown in Figure 7A , K562-V28 adhered to by soluble fractalkine, whereas CD3 ϩ CD4 ϩ T cells were preferentially attracted by TARC. Both CD3 ϩ CD4 ϩ and ECV304 expressing the membrane form of fractalkine 6-fold more than to control ECV304 cells. Also, consis-CD3 ϩ CD8 ϩ T cells were equally attracted by MCP-1. However, only soluble fractalkine induced strong migratent with the results of adhesion of K562-V28 to immobilized Fractalkine-SEAP (Figures 3 and 4) , soluble fractaltion in CD16 ϩ NK cells. Collectively, the phenotypes of cells migrating to soluble fractalkine correlated well to kine almost completely suppressed the adhesion, while PT ϩ EDTA/EGTA had little inhibitory effect on the adheThe previous study demonstrated the ability of fractalkine to support the adhesion of monocytes and T cells sion. Similar results were obtained when we examined the adhesion of K562-V28 to primary HUVEC. As shown when expressed on HEK 293 cells (Bazan et al., 1997) . However, that report did not address whether fractalkine in Figure 7B , K562-V28 cells showed 15-fold more adherence to TNF␣-stimulated HUVEC expressing endogitself was an adhesion molecule or whether it was merely inducing and/or activating other adhesion molecules on enous fractalkine (Bazan et al., 1997) than to control HUVEC. Again, the adhesion of K562-V28 to activated the surface of HEK 293 cells, or leukocytes, or both. The involvement of other adhesion molecules was an espe-HUVEC was strongly inhibited by soluble fractalkine but only marginally affected by PT. Finally, we examined cially compelling notion since the mucin domain of fractalkine is reminiscent of structures seen elsewhere in the adhesion of freshly isolated NK cells expressing endogenous V28 to ECV304 and HUVEC ( Figure 7C ). NK cells realm of adhesion molecules. For example, L-selectin binds to the carbohydrate determinants exposed on the adhered to ECV304 expressing fractalkine 4-fold more than to control ECV304. The enhanced adhesion of NK mucin structure of MAdCAM-1, GlyCAM-1, or CD34 (Girard and Springer, 1995) . Nevertheless, the identification cells to ECV304-fractalkine was strongly inhibited by soluble fractalkine. Similarly, NK cells adhered to TNF␣-of the CX3CR1 has led to findings that do not support this model. In addition, the involvement of other adhesion activated HUVEC 4-fold more than to control HUVEC, and the enhanced adhesion of NK cells to activated molecules seems also precluded. Several lines of evidence in the present study support this view. First, HUVEC was partially but significantly inhibited by soluble fractalkine. In the latter case, involvement of other CX 3 CR1-expressing cells efficiently adhere to purified fractalkine immobilized onto glass slides, showing that adhesion pathways probably accounted for adhesion not inhibited by soluble fractalkine. Collectively, these the adhesion can occur in the absence of substrates for other cell adhesion molecules (Figure 3) . Second, the results support the conclusion that physical interaction of membrane-bound fractalkine and V28 is indeed capaadhesion was robust in the absence of divalent cations, which are required for integrin-or selectin-mediated ble of directly mediating cell adhesion independent of signaling via the PT-sensitive G proteins or downstream adhesion (Figure 3 ) (Springer, 1994) . We also confirmed that 293/EBNA-1 cells do not express CD18, the essenactivation of other adhesion molecules, and that this mode of adhesion can be demonstrated in primary hutial subunit of ␤2 integrins, and K562 cells do not express VLA-4 (data not shown). Furthermore, neutralizing monoman cells as well as cells engineered to express recombinant fractalkine and V28.
clonal anti-CD18, anti-LFA-1, anti-CD29, anti-CD49d, and anti-CD44 had no inhibitory effect on the adhesion (data not shown). Taken together, the evidence suggests Discussion that fractalkine and CX 3 CR1 are molecules capable of directly mediating cell adhesion as well as chemotaxis. The CX 3 C chemokine fractalkine represents a fourth class Fractalkine and the CX 3 CR1 mediate the processes of chemokine, which exhibits properties of both tradiof chemotaxis and adhesion directly, but the machinery tional chemokines and adhesion molecules, raising required for each activity is distinct. The migratory and questions regarding the molecular nature of its receptor calcium mobilization functions controlled by CX 3 CR1 are and how the receptor-ligand complex achieves its hy-G protein-linked and can be inhibited by PT (Figures brid functions. We describe here the identification of 2 and 3). By contrast, adhesion occurs in all CX3CR1 the 7-TM protein encoded by the V28 orphan cDNA as transfected cell lines tested, even in those that do not a specific, high-affinity receptor for fractalkine. Since mobilize calcium to fractalkine or in those that are not the V28 protein represents the first receptor for a CX3C chemotactically responsive to soluble fractalkine (Figure chemokine, we have accordingly designated it as CX3CR1.
3). Adhesion to fractalkine is also insensitive to PT (FigAs in the case for CC and CXC chemokine receptors, ure 3). Thus, the adhesion via fractalkine and CX 3 CR1 CX 3 CR1 is a 7-TM G protein-coupled receptor (Combadoccurs before, and certainly appears to be independent iere et al., 1995; Raport et al., 1995) . CX 3 CR1 contains of, activation of integrins and chemotaxis. This, howseveral motifs conserved among the chemokine recepever, does not exclude the role of CX 3 CR1 signaling via tor superfamily. For example, a DRY motif, which is imthe G␣i class of G proteins in activation of integrins for portant for G protein interactions and signal transducsubsequent firm adhesion. Another notable point is that tion, is present. We showed in the present study that the adhesion mediated by CX3CR1 and fractalkine is calcium mobilization and cell migration responses linked dependent on temperature (Figure 3 ). This may suggest to CX3CR1 were highly sensitive to PT (Figure 2) , indicatinvolvement of some signaling via CX 3 CR1 in the obing coupling to the G␣i class of G proteins. These results served adhesion. It is, however, more likely that memsuggest that, at least in transfected cells, CX3CR1 is brane fluidity is needed for CX 3CR1-expressing cells to capable of interacting with signal transduction machinform multiple associations with immobilized fractalkine ery shared with other CCRs and CXCRs (Campbell et at levels sufficient for cell adhesion. al., 1996) . It may also be noteworthy that, when aligned These results prompted our molecular dissection of phylogenetically with other chemokine receptors, CX 3 CR1 how the fractalkine architecture was important in the is more closely related to CC chemokine receptors than achievement of adhesion with CX 3 CR1. Fractalkine is to those for CXC chemokines. This may relate to its bioapparently a hybrid molecule comprising the CX3C logical specificity for T cells, NK cells, and monocytes, chemokine as an effector domain and the mucin-like which mimic the known activities of CC chemokines stalk as a presentation structure (Bazan et al., 1997) . First, the binding of fractalkine to CX 3 CR1 seems to (Baggiolini et al., 1994; Rollins, 1997) .
be solely the function of the chemokine domain. The NK cells and 2.5% of CD8 ϩ T cells added to the assay migrated ( Figure 6 ). Thus, roughly 10% of the receptorchemokine domain alone bound to CX3CR1 as efficiently as the whole extracellular region of fractalkine, giving a expressing cells of each subset responded to soluble fractalkine in our experimental conditions. Although similar high affinity and number of binding sites ( Figure  4) . With regard to receptor binding, the mucin domain 80% of CD14 ϩ monocytes expressed fractalkine receptors ( Figure 5 ), only 1% of input cells, that is, only 1.3% seemed to have no direct role, since the mucin domain alone showed no binding to CX 3 CR1-expressing cells of the receptor-expressing cells, migrated to soluble fractalkine (Figure 7) . Furthermore, THP-1 cells, a mononor any positive or negative effect on the binding of the chemokine domain to CX 3 CR1 (Figure 4) . Collectively, cytic cell line, migrated to MCP-1 but not to soluble fractalkine, even though they expressed fractalkine rethese results indicate that the chemokine domain is the sole effector domain for CX3CR1, possessing a similar ceptor on the surface (data not shown). These results suggest that the receptor expression per se does not biological activity as other CC, CXC, or C chemokines.
What, then, is the role of the mucin-like domain? We determine migration activity of leukocytes to fractalkine. Fractalkine is likely to be expressed on the cell surface demonstrated that both the chemokine and mucin domains were necessary for efficient adhesion induction of endothelial cells in inflamed tissues (Bazan et al., 1997) . This would induce adhesion of cells such as NK of CX3CR1-expressing cells (Figure 4) . However, the soluble mucin domain alone or the mucin domain linked cells expressing CX 3 CR1. To address this notion, we examined the role of fractalkine in the adhesion of to a CC chemokine TARC did not inhibit cell adhesion mediated by immobilized fractalkine. Furthermore, coim-CX 3 CR1-expressing cells to fractalkine-expressing endothelial cells. K562 cells expressing CX 3 CR1 vigorously mobilization of the chemokine domain and the mucin domain as separate molecules at a 1:1 ratio did not adhered to ECV304 cells expressing transfected fractalkine and to TNF␣-stimulated HUVEC expressing endogsupport the adhesion at all (Figure 4 ). Thus, it seems unlikely that the mucin domain is directly involved in cell enous fractalkine (Figure 7 ). The enhanced adhesion of K562 cells expressing CX 3 CR1 to fractalkine-expressing adhesion as an adhesion domain. Most probably, the mucin domain functions primarily as an efficient presencells was almost completely blocked by soluble fractalkine (Figure 7 ), even though soluble fractalkine itself was tation molecule for the chemokine domain. This, however, does not exclude a potential role of the mucin a potent agonist for CX3CR1 in induction of chemotaxis and calcium mobilization (Figure 3 ). Furthermore, PT or domain in cell adhesion as a ligand for some lectins in natural settings.
EDTA/EGTA had little inhibitory effect on the observed cell adhesion. Thus, the cell-to-cell adhesion promoted In the case of other CC, CXC, or C chemokines, they have to be retained and presented by surface molecules by CX 3 CR1 and membrane-bound fractalkine was also mostly independent of signaling via PT-sensitive G proon endothelial cells, otherwise they are rapidly diluted by blood flow (for review, see Schall and Bacon, 1994) .
teins or divalent cation-dependent integrins and selectins, and thus probably mediated by direct physical asThe heparin-binding property of these chemokines may provide a mechanism for retention in the extracellular sociation of fractalkine and CX 3 CR1. Similarly, freshly isolated NK cells expressing endogenous CX 3 CR1 (Figmatrix or by cell-bound proteoglycan so as to be presented on the endothelial cells for rolling lymphocytes.
ure 5) adhered well to ECV304 cells expressing transfected fractalkine and also to TNF␣-treated primary HUVEC Fractalkine, possessing intrinsically both the chemokine and presentation domains, may represent a parsimoniexpressing endogenous fractalkine (Figure 7) . The adhesion of NK cells to these types of cells was also effecous solution to the presentation problem. Consistent with this idea, even a CC chemokine, TARC, if linked to tively blocked by soluble fractalkine (Figure 7 ). Collectively, the membrane form of fractalkine expressed on the mucin domain of fractalkine, was capable of inducing efficient adhesion of cells expressing its cognate activated endothelial cells indeed induced adhesion of CX 3 CR1-expressing cells such as NK cells. The precise receptor, CCR4 (Figure 4 ). This observation suggests that other chemokine receptors also role of fractalkine in interaction of CX 3 CR1-expressing cells and activated endothelial cells, however, requires have a potential to support adhesion as CX 3 CR1 if chemokines are presented in a structure similar to fractalfurther analysis in more physiological flow conditions. In summary, the identification of CX 3 CR1 illuminates kine. This may lead to a hypothesis that chemokines and their receptors, if the former are presented on molecules unique features in the molecular control of leukocyte such as proteoglycans, are capable of directly mediating trafficking. At the critical interface between leukocyte adhesion of leukocytes as well as signaling for downcell surface and endothelium, fractalkine and CX 3 CR1 stream activation of integrins during the multistep process seem to blend adhesion and chemotactic properties at of leukocyte trafficking (Butcher, 1991; Springer, 1994;  the molecular and functional levels. Aside from enhanc- Butcher and Picker, 1996) .
ing the basic understanding of leukocyte migration, We demonstrated that soluble fractalkine induces mithese molecules may also define new targets for develgration of certain types of leukocytes through endotheopment of antiinflammatory agents. lial cells in a transendothelial migration assay. In accordance with the expression of CX 3 CR1 mRNA and surface cells and 25% of CD3 ϩ CD8 ϩ T cells express fractalkine CCR7, V28/CMKBRL1, BLR1, or GPR-9-6 (GenBank accession number: HSU45982) were described previously .
receptor on the cell surface ( Figure 5 ), and 8% of CD16 ϩ ECV304 cells were obtained from American Type Culture Collection Triton X-100, and heated at 65ЊC for 10 min to inactivate cellular phosphatases. Lysates were collected by centrifugation, and AP and maintained in M199 medium supplemented with 10% FBS. For stable expression of membrane-bound fractalkine in ECV304 cells, activity in 10 l of lysate was determined by the chemiluminescent assay. All assays were done in duplicate. Binding data were anathe expression plasmid pCAGG-Neo-fractalkine-1 was transfected into ECV304 by Lipofectamine (GIBCO-BRL). After selection with lyzed by the LIGAND program. 800 g/ml of G418 for 1-2 weeks, drug-resistant cells were pooled and incubated with an anti-fractalkine MAb (T. I. et al., unpublished Chemotaxis and Calcium Mobilization Assays data). After washing, cells were stained with FITC-conjugated antiCell migration assay in a 48-well microchemotaxis chamber and mouse IgG, and cells expressing membrane-bound fractalkine were across a polyvinylpyrrolidone-free polycarbonate filter (8 m pores) obtained by sorting on a FACStar Plus. Peripheral blood mononuprecoated with type IV collagen was carried out as described preclear cells (PBMC) and granulocytes were isolated from venous viously . Each sample was assayed in triplicate, blood obtained from healthy adult donors as described previously and migrated cells were counted in five randomly selected high- . Further fractionation of lymphocytes into classes power fields (ϫ400) per well. Calcium mobilization assay was carried and subsets was also carried out as described previously (Imai et out as described previously . Transendothelial cheal., 1997). The purity of each cell population was in the range of motaxis assay was carried out by using an endothelial cell line 95%-99% as determined by flow cytometric analysis.
ECV304 as described previously (Carr et al., 1994; Oin et al., 1996) . In brief, ECV304 cells (2 ϫ 10 5 ) were added on Transwell culture Production of Recombinant Proteins inserts (Coaster) with a 5 m pore size and cultured at 37ЊC for 48-96 To express Fractalkine-SEAP, the DNA fragment encoding fractalhr in M199 medium supplemented with 10% FBS. Chemokines were kine was amplified from fractalkine cDNA by PCR using 5Ј SalIdiluted in migration medium (RPMI-1640:M199ϭ1:1, 0.5% BSA) and fractalkine primer (ϩ5Ј-CGCGTCGACTCAGCCATGGCTCCGATA added to 24-well tissue culture plates in a final volume of 600 l. TCT-3Ј) and 3Ј fractalkine-XbaI primer (Ϫ5Ј-CGCTCTAGAGGTGGC Endothelial cell-coated inserts were placed in each well, and 10 6 AGCCTGGGCGTCAGG-3Ј) and subcloned into pDREF-SEAP(His)6-PBMC in 100 l were added to the upper chamber. The cells were Hyg vector as described previously . CX allowed to migrate through endothelial cells to the lower chamber was similarly generated using 5Ј SalI-fractalkine primer (see above)
at 37ЊC for 4 hr. The cell suspensions from the lower chamber were and 3Ј fractalkine-XbaI-2 primer (Ϫ5Ј-CGCTCTAGATAGGGCAGCA then stained with FITC or PE-conjugated MAb to CD3, CD4, CD8, GCCTGGCGGTC-3Ј). For generation of Mucin-SEAP, the DNA frag-CD14, CD16, or CD19. The migrated cells were then counted using ment encoding SalI-oncostatin M signal sequence-XbaI-fractalkine flow cytometry. lacking the chemokine domain NheI was amplified by three-step PCR using 5Ј SalI-OMC-XbaI-fractalkine primer (ϩ5Ј-CTGTTTCCA AGCATGGCGAGCATGTCTAGAAATGGCGGCACCTTCGAGAAG-3Ј) Adhesion Assay and 3Ј fractalkine-NheI primer (Ϫ5Ј-CGCGCTAGCGGTGGCAGCCT Each well of 16-well glass slides was coated with 50 l of anti-SEAP GGGCGTCAGG-3Ј). TARC-SEAP was described previously (Imai et antibody (10 g/ml) in 50 mM Tris-HCl (pH 9.5) at 4ЊC overnight. al., 1997). TARC-mucin-SEAP was generated by replacing oncoAfter washing with PBS, nonspecific binding sites were blocked statin signal sequence of Mucin-SEAP to TARC. 293/EBNA-1 cells with adhesion buffer (RPMI-1640, 1% BSA, 20 mM HEPES [pH 7.4]). were transfected with the expression vectors for various recombi-
The SEAP fusion proteins (10 nM) were added to wells, and the nant proteins by using Lipofectamine (BRL). After 3-4 days, the plates were incubated at room temperature for 2 hr and washed supernatants were collected. For one-step affinity purification, suextensively. Cells (4000 cells/mm 2 ) were applied to each well in final pernatants were applied to 1 ml of Hisbond resin (Qiagen, Hilden, volume at 50 l and incubated for 30 min at room temperature. Germany). After washing, bound recombinant proteins were eluted After washing off nonadherent cells by dipping the slides gently in with 100 mM imidazol. The concentration of each recombinant proadhesion buffer twice, cells were fixed with 1% glutaraldehyde. To tein was determined by a sandwich-type enzyme-linked immunosorassess cell adhesion to endothelial cells, control ECV304 and bent assay as described previously . AP activity ECV304 transfected with the full-length fractalkine cDNA were was determined by a chemiluminescent assay using Great Escape added to wells precoated with polyethyleneimine at 1 ϫ 10 5 cells Detection Kit (Clontech). The enzymatic activity was expressed as per well a day before the assay. Similarly, HUVEC were added to relative light unit (RLUs). wells precoated with fibronectin at 2 ϫ 10 4 cells per well and cultured Soluble fractalkine with a tag of six histidine residues, (His) 6, at for 2 days before the assay. Some HUVEC cultures were treated its C terminus was prepared by using a baculovirus expression with TNF␣ for 10 hr prior to the assay. The purity of NK cells used system. The cDNA fragment encoding the extracellular domain of was in the range of 80%-90% as determined by flow cytometric fractalkine was subcloned into the SalI-XbaI sites of the modified analysis. All assays were performed in duplicate, and the percent pFastBac1 baculovirus transfer vector (GIBCO-BRL) to express adhesion of input cells was determined by counting cells in five fractalkine as a soluble fusion protein with Ser-Arg-Ser-Ser-Gly-400ϫ fields (0.07 mm 2 ) per well. (His) 6 . The recombinant bacmids were generated in E. coli DH10Bac and transfected into Spodoptera frugiperda Sf9 cells using Lipofectin (GIBCO-BRL) to obtain the recombinant viruses. For expression Northern Blot and Flow Cytometric Analysis of the recombinant fractalkine-(His) 6, Trichoplusia ni BTI-TN-5B1-4
Northern blot analysis was carried out as described previously (Imai cells were infected with the recombinant viruses at moi of 10-20. . For flow cytometric analysis of fractalkine receptor, culture supernatants collected 2 days after infection were applied to PBMC or granulocytes were incubated with 10 nM of Fractalkinea 1 ml Hisbond resin (Qiagen). After washing, bound fractalkine-(His) 6 SEAP or control SEAP on ice for 30 min in staining buffer (1% FBS, was eluted with 100 mM imidazol. Fractions containing recombinant 2.5% human AB serum, 0.02% sodium azide in PBS). After washing, fractalkine-(His)6 were pooled and dialyzed to PBS. Protein concencells were incubated with biotinylated anti-SEAP antibody, washed, trations were determined by the BCA kit (Pierce, Rockford, IL). Endoand then incubated with FITC-conjugated streptavidin and PE-contoxin levels were determined by the Limulus amoebocyte lysate jugated antibody for leukocyte subset makers. Cells were then anaassay (QCL-1000) (Bio Whitaker, Walkersville, MD) and were Ͻ4 pg lyzed on a FACStar Plus (Beckton Dickinson, Mountain View, CA). per g of recombinant fractalkine-(His) 6.
Receptor Binding Assay

